PubMed · 1987 · 11 citations · 0 references
MedicineOncologyPharmacotherapyChemotherapyHepatologyOncology PharmacotherapyHepatic PathologyHepatobiliary SurgeryHepatocellular CarcinomaHepatocellular Carcinoma PharmacotherapyLiver CancerLiver DiseaseDoxorubicin-based TherapyHepatic TumorsHepatocellular Carcinoma Treatment
Hepatocellular carcinoma is often an aggressive tumour and, if unresectable, carries a poor prognosis, especially in the presence of jaundice. We report on a jaundiced patient with an unresectable fibrolamellar hepatocellular carcinoma treated with intra-arterial lipiodolised doxorubicin (Adriamycin). The initial response of the patient has been encouraging. This form of therapy deserves further evaluation in patients with unresectable hepatocellular carcinoma.